.Zevra Therapies' uncommon condition medicine appears to become on the path to approval this fall af...
.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) gene treatment failing has actually blown a $230...
.After more than twenty years of focus on neurodegenerative illness, Swiss biotech air conditioner I...
.GSK has scrapped a phase 2 human papillomavirus (HPV) injection from its own pipe after determining...
.Operating system Therapies will note on the NYSE American inventory swap today via a $6.4 million I...
.ALX Oncology's period 2 gastric cancer cells action rate has actually compromised. After seeing its...
.Another of Ionis Pharmaceuticals' key midphase readouts has fallen short of requirements, cuing the...
.While Biogen's pharma peers are actually looking for late-stage resources along with little bit of ...
.Instil Bio has been a biotech seeking a pipe after it ditched its lead assets over the last couple ...
.Biogen has returned civil liberties to an early Alzheimer's condition course to Denali Therapeutics...